KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,964,000 | -16.3% | 909,083 | -30.9% | 0.29% | +0.3% |
| Q2 2022 | $5,934,000 | -40.1% | 1,315,834 | -2.2% | 0.29% | -27.3% |
| Q1 2022 | $9,912,000 | +20.7% | 1,344,929 | +5.3% | 0.40% | +35.7% |
| Q4 2021 | $8,209,000 | +0.6% | 1,276,634 | -8.9% | 0.29% | -3.3% |
| Q3 2021 | $8,159,000 | -43.9% | 1,401,861 | -0.5% | 0.30% | -41.8% |
| Q2 2021 | $14,545,000 | -11.5% | 1,409,397 | -9.8% | 0.52% | -3.5% |
| Q1 2021 | $16,443,000 | -31.6% | 1,563,044 | +0.7% | 0.54% | -36.6% |
| Q4 2020 | $24,033,000 | +13.1% | 1,552,504 | +6.7% | 0.85% | -1.2% |
| Q3 2020 | $21,246,000 | +47.2% | 1,455,222 | +91.0% | 0.86% | +38.3% |
| Q2 2020 | $14,429,000 | +25.9% | 761,819 | +27.7% | 0.62% | -3.4% |
| Q1 2020 | $11,463,000 | – | 596,745 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |